K

NYBC Ventures logo

NYBC Ventures

Crunchbase
Pitchbook
Crunchbase

Deals on record

4

Common Fundraising Type

Equity

Akadeum Life Sciences logo
Akadeum Life Sciences

Cell separation • Flotation technology

Michigan Capital Network logo
Arboretum Ventures logo
NYBC Ventures logo

Akadeum Life Sciences develops flotation-based cell separation technology for biopharma applications, particularly in cell therapies.

Equity
$20M
06/03/2025
Article
AvenCell logo
AvenCell

Cell therapy • CAR-T

Novo Holdings logo
F-Prime Capital logo
NYBC Ventures logo
Piper Heartland Healthcare Capital logo

AvenCell Therapeutics, Inc. develops a Universal Switchable CAR-T cell therapy platform for treating hematologic malignancies and autoimmune diseases.

Series B
$112M
10/22/2024
Article
Aronora logo
Aronora

Biotech • Clinical-stage

NYBC Ventures logo

Aronora is a clinical-stage biotech company focused on advancing blood clot treatment and prevention through the development of innovative drugs.

Equity
Undisclosed
10/16/2023
Article
Star Therapeutics logo
Star Therapeutics

Biotechnology • Antibody Therapies

Sofinnova Investments logo
Westlake Village BioPartners logo
OrbiMed logo
Redmile Group logo

Star Therapeutics is a biotechnology company that develops first-in-class antibody therapies, primarily for hematology and immunology, and also generates additional biotech companies focused on discovering and advancing novel antibody therapies.

Series C
$90M
09/05/2023
Article